Related by context. All words. (Click for frequent words.) 71 kidney urologic 69 pain palliation 68 CYT# potent vascular disrupting 68 Hepatocellular Carcinoma HCC 68 QuadraSphere 68 fusion enhancers 67 palliative radiotherapy 67 R sorafenib tablets 67 genomic biomarker 67 Warfarin Coumadin 67 refractory colorectal cancer 66 myoblast therapy 66 K ras mutations 66 neovascular diseases 66 neratinib 66 docetaxel Taxotere ® 66 BEXXAR Therapeutic Regimen 66 sorafenib tablets 66 clevidipine 66 novel VDA molecule 66 recurrent glioblastoma multiforme 66 paclitaxel poliglumex 66 Li Fraumeni Syndrome 66 prognostic indicators 66 papillary renal cell carcinoma 66 eTag assays 66 pharmacodynamic markers 66 MAGE A3 ASCI 66 Evoltra ® 66 anti angiogenic agents 66 Vidaza ® 65 metastatic lymph nodes 65 SUTENT ® 65 coronary stent merged 65 unresectable tumors 65 recurrent metastatic 65 Surgical resection 65 myelofibrosis polycythemia vera 65 abnormal p# 65 antiangiogenic therapy 65 Proxinium TM 65 thetreatment 65 KRAS mutation 65 candidates Azedra TM 65 ixabepilone 65 pediatric malignancies 65 demonstrated antitumor activity 65 primary hyperparathyroidism 65 humanised monoclonal antibody 65 fosbretabulin 65 metastatic pancreatic 65 Allovectin 7 ® 65 ADVEXIN clinical 65 OnDose TM 65 CINQUIL 65 LHRH receptor positive 64 trastuzumab Herceptin ® 64 novel emulsion formulation 64 number NCT# ClinicalTrials.gov 64 gefitinib Iressa 64 refractory chronic lymphocytic 64 p# biomarker 64 hypervascular tumors 64 alemtuzumab MS 64 Deforolimus 64 radiochemotherapy 64 TRIOLEX HE# APOPTONE HE# 64 Certolizumab pegol 64 metastatic neuroendocrine tumors 64 lymphomas leukemias 64 prognostic markers 64 metastatic colorectal 64 thoracoscopic lobectomy 64 prognostic variables 64 nodal metastasis 64 pharmacodynamic parameters 64 Targretin capsules 64 thalidomide Thalomid 64 Virulizin ® 64 molecular determinants 64 sunitinib Sutent 64 biliary tract cancer 64 gemcitabine Gemzar ® 64 either acutely decompensated 64 PrevOnco 64 Trofex 64 OncoVex 64 Temsirolimus 64 NB S# strontium malonate 64 irinotecan oxaliplatin 64 antiplatelet medications 64 chronic myocardial ischemia 64 pancreatic prostate 64 oral picoplatin 64 GERD migraine headaches 64 Randomized clinical trials 64 Interferon beta 64 Ceflatonin 64 Zenvia ™ 64 squamous cell lung cancer 64 recurrent metastatic ovarian cancer 64 Hedgehog inhibitor 64 stratifying patients 64 pharmacogenomic tests 64 percutaneous biopsy 63 pancreatic adenocarcinoma 63 malignant ascites 63 investigational therapies 63 chemo immunotherapy 63 Advexin 63 Rilonacept 63 prostate carcinoma 63 patientswith 63 Aviptadil 63 Dacogen injection 63 BrachySil TM 63 esophagogastric 63 antiangiogenic agent 63 relapsed SCLC 63 p# biomarkers 63 OPAXIO 63 IRX 2 63 ZOLINZA 63 cMET 63 pharmacogenomic translational research 63 vascular insufficiency 63 bevacizumab Avastin ® 63 Pyridorin 63 Trobalt 63 recurrent NSCLC 63 RIGScan CR 63 K RAS 63 eprodisate Fibrillex TM 63 treating neuropathic pain 63 clinico pathological 63 Safinamide 63 investigational monoclonal antibody 63 Thalomid ® 63 thromboembolic disease 63 HuMax EGFr 63 Lymph node 63 Fludara ® 63 Umbilical cord stem cells 63 pancreatic neuroendocrine tumors 63 STRIDE PD 63 cardiac resynchronisation therapy 63 R Saizen R 63 Prognostic factors 63 NV1FGF 63 Trastuzumab DM1 63 biostatistical analysis 63 Known hypersensitivity 63 constipation OIC 63 PI3K/Akt pathway inhibitor 63 cisplatin gemcitabine 63 choroidal vasculopathy 63 Aggrastat ® tirofiban hydrochloride 63 gastrointestinal mucositis 63 pretransplant 63 gastrointestinal stromal tumors GIST 63 neoadjuvant therapy 63 gastrointestinal stromal tumors GISTs 63 surgically resectable 63 ADVEXIN 63 CTAP# Capsules 63 MGN# 63 CEQ# 63 mutated K ras 63 colorectal liver metastases 63 CINTREDEKIN BESUDOTOX 63 UPLYSO 63 TORISEL 63 CONBRIZA 63 R lenalidomide 63 catheter occlusion 63 Xelox 63 fluoropyrimidine 63 vemurafenib 63 Tumor Response 62 Tectin TM 62 HuMax TAC 62 Squalamine 62 denileukin diftitox 62 NAVISTAR R 62 Vascugel R 62 superficial basal cell carcinoma 62 including eniluracil ADH 62 Velcade bortezomib 62 Sipuleucel T 62 Perforomist ™ Inhalation Solution 62 haematologic 62 deCODE ProstateCancer TM 62 concurrent chemoradiation 62 Solazed TM 62 EDEMA3 trial 62 atrial tachyarrhythmias 62 rxRNA 62 non resectable metastatic 62 Bayer HealthCare Onyx Pharmaceuticals 62 rheumatoid arthritis osteoarthritis ankylosing 62 angiogenic therapy 62 thrombo embolic 62 taxane therapy 62 efficacy tolerability 62 EGFR pathway 62 YONDELIS 62 psoriasis Crohn disease 62 LHRH antagonists 62 ALK inhibitors 62 transthyretin amyloidosis 62 castrate resistant prostate cancer 62 EEG abnormalities 62 EndoTAGTM 1 62 immunological diseases 62 metastatic GIST 62 Cimzia TM 62 oral ridaforolimus 62 Anti Bacterial Envelope 62 Urocidin TM 62 chimeric monoclonal antibody 62 Combidex 62 AA Amyloidosis 62 hoFH 62 non metastatic osteosarcoma 62 Removab 62 novel therapeutic antibodies 62 recurrent malignant glioma 62 deCODE AF TM 62 intra arterial chemotherapy 62 FOLOTYN ® 62 allogeneic hematopoietic cell 62 hematopoietic cancers 62 metastatic gastric 62 chronic myeloid 62 vidofludimus 62 systemic fungal infections 62 anticancer therapy 62 NATRECOR ® 62 BRIM2 62 HGS ETR1 mapatumumab 62 erythema nodosum 62 fibrotic disease 62 TroVax ® 62 Vascugel ® 62 recurrent glioma 62 ImmuKnow assay 62 monoclonal antibody therapeutics 62 Sudhir Agrawal D.Phil 62 Panzem 62 Xanafide 62 breast endometrial 62 acetonide FA 62 efalizumab 62 radiolabeled TM# 62 Canvaxin TM 62 Adjuvant chemotherapy 62 riociguat 62 Relapsing remitting MS 62 oral dnaJP1 62 hematologic disorders 62 TELINTRA 62 lenalidomide dexamethasone 62 carcinoma HCC 62 Tasigna prolongs 62 Hexvix ® 62 allogeneic HSCT 62 Arranon 62 Phase IIb III 62 relapsed MM 62 florbetaben 62 Zemiva TM 62 samalizumab 62 Tarceva TM 62 lung liver pancreas 62 HERmark assay 62 Entereg R 62 GW# [003] 62 overactive bladder syndrome 62 commercialize deforolimus 62 Surgical excision 62 HCV protease inhibitors 62 orally inhaled migraine 62 ReN# 62 hypereosinophilic syndrome 62 PDE# inhibitors 62 receptor tyrosine kinase inhibitor 62 intra abdominal infections 62 CTEPH 62 histologies 62 smoldering multiple myeloma 62 multicenter Phase II 62 Vidaza azacitidine 62 chronic thromboembolic pulmonary 62 adrenocortical cancer 62 immunotherapeutic approaches 62 molecular biomarkers 62 gastric adenocarcinoma 62 ZACTIMA TM ZD# 62 completely resected 62 GRNCM1 62 DCVax ® Brain 62 Rheos System 62 ENMD # 62 alpha1 antitrypsin deficiency 62 zalutumumab 62 hepatocellular liver 62 variant angina 62 venous stasis ulcers 62 novel oral anticoagulant 62 HepaMate 62 Vicinium TM 62 Zybrestat 62 diabetic kidney 62 intravenous methylnaltrexone 62 drotrecogin alfa activated 62 ATPace TM 62 pharmacokinetic equivalence 62 colorectal adenocarcinoma 62 colorectal lung 62 benign prostatic hyperplasia enlarged 62 spinal metastases 62 cellular immunotherapy 62 methylation markers 62 tumor histology 62 lung pancreatic 62 invasive candidiasis 62 r hGH 62 iroxanadine 62 differentiate squamous 62 tumor subtypes 62 NMIBC 62 relapsed ovarian cancer 62 atherothrombotic 62 prospectively stratified 62 pharmacokinetic PK study 62 Genasense ® 61 Hematologic 61 ATIR ™ 61 genotypic resistance 61 TLR antagonists 61 multivessel coronary artery 61 treat chronic sinusitis 61 recurrent glioblastoma 61 Mepact 61 deCODE BreastCancer 61 T#I [002] 61 DCVax R 61 advanced medullary thyroid 61 DaTscan 61 opioid naive 61 ablative therapy 61 PrevOnco ™ 61 galiximab 61 intravesical infusion therapy 61 prostate carcinomas 61 neoplastic diseases 61 Inhaled nitric oxide 61 motesanib 61 Rasilamlo 61 Pegloticase 61 TTR amyloidosis 61 metaglidasen 61 Metastatic breast cancer 61 CRMD# 61 metastatic colorectal carcinoma 61 paclitaxel Taxol ® 61 urothelial carcinoma 61 osteoporotic compression fractures 61 Degarelix 61 TWYNSTA 61 sapacitabine CYC# 61 refractory prostate cancer 61 KRAS status 61 epithelial tumors 61 Allovectin 7 61 plus dacarbazine 61 erlotinib Tarceva ® 61 liposomal doxorubicin 61 refractory metastatic 61 GI motility disorders 61 TRIST study 61 mTOR kinase 61 oral deforolimus 61 liver metastasis 61 bladder ovarian 61 Pafuramidine 61 mTOR inhibition 61 Multivariate logistic regression 61 Gamunex C 61 PROSTVAC ® 61 AVASTIN 61 OvaRex R 61 severe gastroparesis 61 relapsed MCL 61 Cardiotoxicity 61 pediatric acute lymphoblastic 61 immunosuppressive therapies 61 MelaFind R 61 serum biomarkers 61 ONCASPAR 61 AAG geldanamycin analog 61 recurrent squamous cell carcinoma 61 hematopoietic malignancies 61 gemcitabine carboplatin 61 sorafenib Nexavar 61 induced macular edema 61 XYOTAX TM 61 ToGA 61 diagnostic biomarker 61 Fibrillex TM 61 Bucindolol 61 CYP#A# substrate 61 prospective multicentre 61 MiStent DES 61 humanized therapeutic 61 cisplatin resistant 61 ospemifene 61 Azedra 61 adjuvant systemic 61 mycosis fungoides 61 Zemplar Capsules 61 Campath alemtuzumab 61 refractory acute myeloid 61 calcineurin inhibitor 61 biologic antibody 61 SNT MC# 61 PD2i CA Cardiac Analyzer 61 trial evaluating PRX# 61 receiving chemoradiation therapy 61 RCW breast cancer 61 LPLD 61 essential thrombocythemia ET 61 biomarker identification 61 radiofrequency ablation RFA 61 PROCRIT ® 61 interferon gamma 1b 61 Menopausal hormone therapy 61 pancreas esophagus 61 nonsmall cell lung cancer 61 Pirfenidone 61 CellSearch System 61 Novartis Afinitor 61 transarterial 61 ovarian breast 61 SPRYCEL ® 61 metastatic malignant 61 somatostatin analogues 61 busulfan 61 pancreatic colon 61 EXJADE 61 HuLuc# 61 VeriStrat 61 genomic biomarkers 61 metastatic carcinoid 61 PROSTVAC TM 61 Proxinium 61 R roscovitine 61 Zevalin consolidation 61 Rigel R# 61 edifoligide E2F Decoy 61 coagulation disorders 61 IONSYS TM 61 vapreotide acetate 61 cervical prostate 61 p# inhibitor 61 CTO recanalization 61 biologic pathways 61 vinca alkaloid 61 IL# PE#QQR 61 Gleevec resistant 61 preclinically 61 known sulfonamide allergy 61 kinase inhibition 61 ORENCIA R 61 generation purine nucleoside 61 liposome formulation 61 Oracea TM 61 mild hepatic impairment 61 peritoneal carcinomatosis 61 IMiDs 61 PLX STROKE targeting 61 Venous thromboembolism 61 tropism testing 61 palifermin 61 echocardiographic parameters 61 anthracycline chemotherapy 61 BR.# 61 intracerebral haemorrhage 61 Onalta TM 61 polycythemia vera PV 61 DNA methylation patterns 61 management biostatistical analysis 61 Panzem R NCD 61 basal cell carcinoma BCC 61 GAMMAGARD 61 NPM1 mutation 61 IMiDs ® compound 61 refractory CLL 61 Secondary efficacy endpoints 61 immuno modulatory 61 Muraglitazar 61 ELACYT 61 diabetic retinopathy DR 61 NSCLC tumors 61 preclinical efficacy 61 PLX MS 61 ISTODAX 61 HDL Selective Delipidation 61 Cloretazine 61 Personalized Immunotherapy 61 angiogenesis inhibition 61 therapeutic regimens 61 Prostate AdenoCarcinoma Treatment 61 TEMODAL 61 Dementia Related Psychosis 61 C1 INH deficiency 61 Golimumab 61 skeletal metastases 61 Aeolus Pharmaceuticals Announces 61 MET amplification 61 sipuleucel T 61 Tß4 61 Decitabine 61 levodopa induced 61 INS# [001] 61 Bazedoxifene 61 OvaRex ® MAb 61 naronapride 61 Insegia 61 sodium thiosulfate STS 61 neuropathic pain spasticity 61 Colon polyps 61 HIF PH inhibitors 61 Vectibix panitumumab 61 dyslipidemia hypertension diabetes 61 Renal Cell Carcinoma RCC 61 Evoltra 61 EGFR inhibitors 61 Temodar ® 61 Antisoma AS# 61 alvespimycin 61 Zavesca r 61 KRAS mutant 61 antithrombotic therapy 61 Xcytrin R 61 spontaneous regression 61 TYZEKA 61 Inhaled AAT 61 TNF blocker therapy 61 Metastatic colorectal cancer 61 Onrigin 61 MYLOTARG 61 Phase #b/#a clinical 60 urothelial cancer 60 ZYBRESTAT fosbretabulin 60 antiangiogenic agents 60 antiplatelet therapies 60 localized renal 60 oral FTY# 60 therapeutic monoclonal antibody 60 Onconase 60 Romiplostim 60 BCG refractory carcinoma 60 trastuzumab DM1 T DM1 60 NP2 Enkephalin 60 Gliadel Wafer 60 alpha interferons 60 Clolar ® 60 NPM1 mutations 60 ZYTIGA 60 morphometric vertebral fractures 60 bronchopulmonary dysplasia BPD 60 TLK# 60 microtubule inhibitor 60 G CSFs 60 tanespimycin 60 rhITF 60 multiple myeloma MM 60 plasma kallikrein inhibitor 60 relapsing remitting MS RRMS 60 mda 7 60 predictive biomarker 60 diagnostic molecular imaging 60 tumor metastases 60 Microwave Ablation System 60 INSPIRE Trial Phase III 60 evaluating Prochymal 60 cardioverter defibrillator 60 subependymal giant cell 60 minimally symptomatic 60 tumor subtype 60 mTOR mammalian target 60 recombinant PSMA vaccine 60 ® bortezomib 60 EGS# 60 gadobutrol 60 Kit CD# positive 60 trastuzumab Herceptin R 60 prostate cancer CaP 60 pancreatic islet cell 60 Sentinel node biopsy 60 HER2 overexpression 60 superficial bladder cancer 60 hyperphenylalaninemia HPA due 60 gastric carcinomas 60 prognostic biomarker 60 Platinol ® cisplatin 60 neo adjuvant 60 Prednisone Against Refractory 60 Corgentin 60 Prodarsan R 60 dermatologic diseases 60 visit www.rtanswers.org 60 G#DT 60 Liprotamase 60 extramedullary 60 ImmuKnow R 60 lymphatic mapping 60 QTc prolongation 60 prognostic biomarkers 60 carotid artery stenting 60 Glioblastoma Multiforme GBM 60 etanercept Enbrel 60 endocrine therapies 60 Chemophase 60 benign prostatic hypertrophy BPH 60 GRNOPC1 contains 60 nonclinical studies 60 esophageal gastric 60 systemic anaplastic large 60 CMV vaccine 60 Aplidin 60 ADME properties 60 Zalypsis 60 cardiac repolarization 60 LymphoStat B TM 60 co receptor tropism 60 prophylactic cranial irradiation 60 gastro intestinal stromal tumors 60 kidney fibrosis 60 Hedgehog Pathway Inhibitor 60 nosocomial pneumonia 60 basal bolus regimen 60 Vorinostat 60 MGd 60 Provecta TM 60 brivaracetam 60 chemotherapeutic regimen 60 GVAX Pancreas Vaccine 60 STEDESA 60 OMNARIS HFA 60 Cx# [002] 60 LEUKINE 60 Seliciclib 60 anaphylactic reactions bronchospasm 60 oxaliplatin Eloxatin 60 paclitaxel Taxol R 60 postoperative chemotherapy 60 included exfoliative dermatitis 60 Initiate Clinical Trial 60 SYN# 60 modified glutathione analog 60 adjuvant GIST 60 Shortened telomeres 60 symptomatic paroxysmal AF 60 leiomyomas 60 REMINYL ® 60 AFRS TM 60 NCCN guidelines 60 acadesine 60 immune modulating 60 pulmonary hypertension PH 60 tumor xenograft models 60 chronic granulomatous disease 60 thiopurine drugs 60 Edwards SAPIEN valve 60 gemcitabine chemotherapy 60 aMCI precursor 60 metastatic androgen independent 60 Ribavirin causes 60 Cardiopulmonary bypass 60 anti angiogenic therapy 60 oral Janus kinase 60 cetuximab Erbitux 60 Soliris eculizumab 60 Non inferiority 60 GED aPC 60 novel immunotherapies 60 chemosensitivity 60 Certican 60 aerosolized surfactant 60 PSMA ADC 60 myeloproliferative diseases 60 Silodosin 60 PresbyLens ® 60 membranous nephropathy 60 DNAwithPap TM Test 60 ZFP Therapeutics 60 prehospital setting 60 non selective NSAIDs 60 thymic carcinoma 60 Chronic lymphocytic leukemia 60 asymptomatic hyperuricemia 60 Stage IIB 60 BLA filing 60 medically inoperable 60 vaso occlusive crisis 60 Sanvar R 60 ZFP TF 60 hypoxia activated prodrug 60 EGFR HER2 60 triphendiol 60 Immunotherapeutic 60 cediranib 60 imexon 60 repair TEVAR 60 anastomotic devices 60 pegylated interferon peg IFN 60 anthracycline taxane 60 HQK 60 Neuradiab 60 inhaled bronchodilators 60 myeloproliferative 60 Diabetic Macular Edema DME 60 doxorubicin Adriamycin 60 vascular disrupting agents 60 PEG SN# 60 hepatocellular carcinoma liver 60 chemoradiotherapy 60 metastatic HRPC 60 StemEx R 60 GEM OS2 60 colorectal ovarian 60 OVATURE 60 Tekamlo 60 eosinophilic pneumonia 60 CIMZIA TM certolizumab pegol 60 multimodality imaging 60 chemoresistant 60 radiation chemoradiation 60 Retisert 60 TheraSphere 60 ConclusionThis 60 weekly subcutaneous injections 60 intracavitary 60 BENICAR HCT 60 Generx TM 60 diarrhea predominant irritable 60 PolyHeme ® 60 M# rationally 60 secondary hyperparathyroidism 60 CaPSURE 60 Afatinib 60 5 fluorouracil leucovorin 60 viral kinetics 60 Actimmune ® 60 dopaminergic therapy 60 biochemical profiling 60 Optiquel ™ 60 vismodegib 60 CDK inhibitors 60 Targretin 60 retinal vein occlusion induced 60 ticagrelor Brilinta 60 TTF Therapy 60 Nexavar sorafenib 60 histamine dihydrochloride 60 endothelin antagonists 60 FFR measurements 60 liposomal amphotericin B 60 Edge STudy 60 BRILINTA 60 BEZ# 60 poststroke depression 60 evaluating tivozanib 60 TNF Tumor Necrosis Factor 60 Shark cartilage 60 HeartNet 60 AGHD 60 microsphere therapy 60 antitumor effect 60 pemetrexed Alimta 60 lymph node enlargement 60 Uncontrolled hypertension 60 anticancer treatments 60 NEUVENGE 60 PROCHYMAL 60 antiangiogenesis therapies 60 MyVax R 60 Ultrasonographic 60 pertuzumab 60 Zarnestra 60 Solazed 60 ularitide 60 Lilly Gemzar 60 PDX pralatrexate 60 ALN HTT 60 OrCel 60 Catena ® 60 EDEMA3 60 metastatic castration resistant 60 renal failure interstitial lung 60 autologous hematopoietic stem cell 60 Achieves Primary Endpoint 60 DAVANAT 60 ARIKACE ™ 60 ductal carcinomas 60 ZACTIMA 60 NeuroSTAT ® 60 Vitrasert R 60 tramiprosate Alzhemed TM 60 metastatic malignant melanoma 60 epigenetic therapies 60 Mitomycin C 60 gastric carcinoma 60 GENZ # 60 Progenta TM 60 ADAGIO study 60 Bayer Onyx 60 JAK#/JAK# inhibitor CYT# 60 extrapulmonary disease 60 Sapacitabine 60 VP# [004] 60 HGS ETR2 60 biomarker assays 60 hypokalemia hypomagnesemia 60 TRANSDUR ® 60 CARE HF 60 EGFR mutation status 60 lumiliximab 60 nonischemic 60 TransVax ™ 60 myelodysplastic myeloproliferative diseases 60 sarcoma melanoma 60 oropharyngeal candidiasis 60 coinfected patients 60 EGFR tyrosine kinase inhibitors 60 NovoTTF #A System 60 Eisenmenger syndrome 60 Levulan ® PDT 60 clinicopathological 60 BioNumerik 60 cytogenetic abnormalities 60 Romidepsin 60 rFVIIa 60 nilotinib Tasigna ® 60 mucinous 60 Ph + acute lymphoblastic 60 KRAS mutations 60 pharmacodynamic endpoints 60 Sentinel Lymph Node Biopsy 60 Pemetrexed 60 trastuzumab emtansine T DM1 60 proteasome inhibitor 60 blood clot dissolver 60 anti angiogenic drugs 60 inhibit platelet function 60 nonmetastatic 60 successfully commercialize Iluvien 60 Tesmilifene 60 nonpharmacologic 60 evaluating REVLIMID 60 neurosensory 60 precursor lesions 60 HoFH 60 cystic fibrosis chronic pancreatitis 60 prospective observational studies 60 EOquin 60 systemic mastocytosis 60 RhuDex R 60 MKC# MT 60 Cloretazine R 60 icatibant 60 Accelerated Partial Breast Irradiation 60 trastuzumab DM1 60 Radical prostatectomy 60 predictive biomarkers 60 Intravenous CP 59 chemoradiation therapy 59 Provectus Pharmaceuticals specializes 59 hESC derived cardiomyocytes 59 SIMPONI TM 59 acute coronary syndromes ACS 59 follicular Non Hodgkin 59 methylation biomarkers 59 opioid induced constipation OIC 59 radiology peripheral vascular 59 selective modulator 59 cutaneous lupus 59 prostate cancer CRPC 59 prokinetic agent 59 metastatic uveal melanoma 59 HIV coinfected 59 HERCEPTIN 59 adjuvant colon cancer 59 opioid tolerant adult 59 AzaSite Plus 59 non squamous 59 AGGRASTAT R tirofiban hydrochloride 59 relapsing multiple sclerosis 59 FOSAMAX PLUS D 59 pharmacogenetic testing 59 INTEGRILIN R 59 oxypurinol 59 forodesine 59 personalized immunotherapy 59 INVEGA ™ 59 Methylnaltrexone 59 histological subtype 59 stage IIIb IV 59 Cancidas 59 erlotinib Tarceva 59 hA# 59 lymphoid tumors 59 drug zotarolimus 59 Exherin TM 59 pulmonary artery hypertension 59 LibiGel ® 59 trastuzumab Herceptin 59 ddRNAi 59 Altera Nebulizer System 59 HuMax 59 toxigenic Clostridium difficile 59 hepatoma 59 Rosetta Genomics microRNA 59 Noxafil 59 nomograms 59 Cathepsin B 59 Sanofi Aventis Taxotere 59 preclinical pharmacokinetic 59 bortezomib Velcade 59 cetuximab Erbitux ® 59 aerosolized KL4 surfactant 59 evaluating picoplatin 59 arterial thrombosis 59 PCNSL 59 benign neoplasms 59 ELOXATIN 59 neurotrophic 59 rALLy trial 59 Angiox ® 59 Nektar proprietary 59 rituximab Rituxan 59 renal carcinoma 59 thrombotic thrombocytopenic purpura TTP 59 LymphoStat B belimumab 59 Quinamed 59 varespladib 59 severe oral mucositis 59 HuMax HepC 59 hematological parameters 59 myeloproliferative disorders 59 thromboembolic complications 59 ImmuKnow 59 Bystolic nebivolol 59 Peritoneal Mesothelioma 59 bronchoscopic 59 OvaRex MAb 59 Panzem R 59 Alequel 59 IMC #B 59 HE4 test 59 tumor necrosis 59 HER2 positive metastatic 59 allergic airway inflammation 59 Prostacyclin 59 Cardio Vascu Grow 59 LEAPS H#N# 59 Heavy snorers 59 dimebon latrepirdine 59 androgen independent 59 anthracyclines taxanes 59 endoscopic ultrasound EUS 59 candidate deforolimus 59 torsemide ER 59 MGuard ™ 59 favorable pharmacokinetic profile 59 Chronic pancreatitis 59 Sphingomab TM 59 severe hypersensitivity reactions 59 acyclovir Lauriad R 59 carcinoid 59 myocardial infarction ventricular fibrillation 59 biotherapy 59 androgen ablation therapy 59 Fingolimod 59 DNA methylation markers 59 cetuximab Erbitux R 59 ovarian pancreatic 59 HER2 expression 59 tubulin inhibitor 59 Egrifta 59 antiarrhythmic drug 59 DCVax 59 Albuferon albinterferon alfa 2b 59 efaproxiral 59 cytokine refractory 59 Brodmann Area 59 liver resection surgeries